Oncosuppressor-Mutated Cell-Based Diagnostic Platform for Liquid Biopsy Diagnoses Benign Head and Neck Masses and Predicts Malignancy in Thyroid Nodules: Results from a Consecutive Cohort of Patients
Conclusions: These data show that liquid biopsy combined with an OMC-based in vivo platform has the potential to diagnose benign head and neck masses and predict whether a thyroid nodule is malignant. These results strengthen the concept that OMCs can be used to detect circulating malignant factors in cancer patients.Eur Thyroid J
Source: European Thyroid Journal - Category: Endocrinology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Endocrinology | Head and Neck Cancer | Thyroid | Thyroid Cancer